Shenzhen Salubris Pharmaceuticals Co Ltd Strategic Asset Allocation Index
Shenzhen Salubris Pharmaceuticals Co Ltd strategic asset allocation index. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Strategic Asset Allocation Index of 18.8% as of September 2023. Strategic assets (PP&E of CN¥1.49 Billion plus long-term investments of CN¥-) total CN¥1.49 Billion, measured against net assets of CN¥7.95 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible equity quality of Shenzhen Salubris Pharmaceuticals Co Ltd to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shenzhen Salubris Pharmaceuticals Co Ltd (2009–2021)
Strategic asset allocation index of Shenzhen Salubris Pharmaceuticals Co Ltd from 2009 to 2021. This chart shows how Shenzhen Salubris Pharmaceuticals Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2009 to 2021. As of September 2023, the index stands at 18.8%, representing strategic assets of CN¥1.49 Billion against net assets of CN¥7.95 Billion CNY.
Shenzhen Salubris Pharmaceuticals Co Ltd Strategic Asset Allocation Index by Year (2009–2021)
Shenzhen Salubris Pharmaceuticals Co Ltd strategic asset allocation index by year from 2009 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Salubris Pharmaceuticals Co Ltd from 2009 to 2021, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shenzhen Salubris Pharmaceuticals Co Ltd stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 20.4% | CN¥1.64 Billion | CN¥1.64 Billion | CN¥- | CN¥8.05 Billion | ▼ -6.6 pp |
| 2020 | 27.0% | CN¥1.51 Billion | CN¥1.51 Billion | CN¥- | CN¥5.59 Billion | ▲ +5.8 pp |
| 2019 | 21.2% | CN¥1.41 Billion | CN¥1.41 Billion | CN¥- | CN¥6.67 Billion | ▼ -7.7 pp |
| 2018 | 28.9% | CN¥1.98 Billion | CN¥1.27 Billion | CN¥718.04 Million | CN¥6.87 Billion | ▲ +4.4 pp |
| 2017 | 24.4% | CN¥1.51 Billion | CN¥1.18 Billion | CN¥324.76 Million | CN¥6.16 Billion | ▲ +3.8 pp |
| 2016 | 20.6% | CN¥1.13 Billion | CN¥1.08 Billion | CN¥44.26 Million | CN¥5.46 Billion | ▼ -1.5 pp |
| 2015 | 22.1% | CN¥1.04 Billion | CN¥1.04 Billion | CN¥- | CN¥4.70 Billion | ▼ -0.9 pp |
| 2014 | 23.0% | CN¥871.99 Million | CN¥871.99 Million | CN¥- | CN¥3.79 Billion | ▼ -6.9 pp |
| 2013 | 29.9% | CN¥938.68 Million | CN¥938.68 Million | CN¥- | CN¥3.13 Billion | ▲ +1.3 pp |
| 2012 | 28.6% | CN¥746.66 Million | CN¥746.66 Million | CN¥- | CN¥2.61 Billion | ▼ -0.3 pp |
| 2011 | 29.0% | CN¥618.35 Million | CN¥618.35 Million | CN¥- | CN¥2.13 Billion | ▲ +7.4 pp |
| 2010 | 21.6% | CN¥402.60 Million | CN¥402.60 Million | CN¥- | CN¥1.87 Billion | ▲ +11.7 pp |
| 2009 | 9.9% | CN¥159.92 Million | CN¥159.92 Million | CN¥- | CN¥1.62 Billion | — |